Pharmaceutical ad watch – Glaxo receives a wrist slap
“The U.S. Food and Drug Administration warned GlaxoSmithKline Plc on Thursday about misleading advertisements touting its hypertension drug called Coreg.
The company presented the marketing information at a conference last June, using posters that omitted risk information and overstated how well the drug worked, the FDA said in a letter posted on its Web site.”
Coreg is actually a pretty good medication, and has been shown to save lives in systolic heart failure.
